Impella RP System, Impella RP with Smart Assist System, Impella RP Flex System
Abiomed, Inc. · Decision date Feb 6, 2026
What did the FDA approve?
FDA records P170011/S061 as a supplement to PMA P170011, with the supplement type “Real-Time Process”. The recorded decision is approval, dated Feb 6, 2026.
FDA approval order statement
approval for a modification to the Instructions for Use to allow sodium bicarbonate to be used in the purge fluid for the Impella catheters if heparin should not be used per the physicians clinical judgement.
- Regulatory pathway
- PMA supplement
- Supplement type
- Real-Time Process
- Clinical specialty
- Cardiovascular
- Decision date
- Feb 6, 2026
- FDA change category
- Labeling Change - Indications/instructions/shelf life/tradename
Regulatory record facts
- Identifier
- P170011/S061
- Regulatory pathway
- PMA supplement
- Applicant
- Abiomed, Inc.
- Product code
- PYX
- Decision code
- APPR
- Decision date
- Feb 6, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Temporary non-roller type right heart support blood pump.
- Applicant
- Abiomed, Inc.
- Product code
- PYX
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P170011. Subsequent supplements may change the device or its indications.
FDA decision timeline
P170011 · Original PMA
Impella RP System
P170011/S059 · Related supplement
Impella RP, Impella RP with SmartAssist, and Impella RP Flex with SmartAssist
P170011/S056 · Related supplement
Impella RP System; Impella RP with SmartAssist System; Impella RP Flex with SmartAssist System;
P170011/S058 · Related supplement
Purge Cassette
P170011/S060 · Related supplement
Impella RP, Impella RP with SmartAssist, Impella RP Flex with SmartAssist
P170011/S061 received
Application receipt date recorded by FDA.
P170011/S062 · Related supplement
Impella CP with SmartAssist; Impella 5.5 with SmartAssist
P170011/S061 · FDA decision
Real-Time Process
P170011/S063 · Related supplement
Impella RP System
P170011/S064 · Related supplement
Impella RP Flex with SmartAssist
Timeline entries are records held by MedtechLedger for P170011. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P170011
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Impella RP SystemP170011 | Abiomed, Inc. | PMA approval | Sep 20, 2017 | FDA |
| Abiomed, Inc. | PMA supplement | Jul 25, 2025 | FDA | |
| Abiomed, Inc. | PMA supplement | Aug 1, 2025 | FDA | |
Purge CassetteP170011/S058 | Abiomed, Inc. | PMA supplement | Sep 15, 2025 | FDA |
| Abiomed, Inc. | PMA supplement | Sep 19, 2025 | FDA | |
| Abiomed, Inc. | PMA supplement | Dec 19, 2025 | FDA | |
Impella RP SystemP170011/S063 | Abiomed, Inc. | PMA supplement | Apr 1, 2026 | FDA |
Impella RP Flex with SmartAssistP170011/S064 | Abiomed, Inc. | PMA supplement | Oct 26, 2026 | FDA |
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
FDA describes the real-time supplement process as a review route for minor changes to a device, including certain design, software, sterilization or labeling changes.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Abiomed, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 22 Cherry Hill Dr., Danvers, MA, 01923
Sources and methodology
- Original FDA record: P170011/S061
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records





